Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:53 PM
Study NCT ID:
NCT00258856
Status:
COMPLETED
Last Update Posted:
2014-02-14
First Post:
2005-11-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-24
First Submit QC Date:
None
Study First Post Date:
2005-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-10-19
Results First Submit QC Date:
None
Results First Post Date:
2009-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-21
Last Update Post Date:
2014-02-14
Last Update Post Date Type:
ESTIMATED